BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Senthebane DA, Rowe A, Thomford NE, Shipanga H, Munro D, Mazeedi MAMA, Almazyadi HAM, Kallmeyer K, Dandara C, Pepper MS, Parker MI, Dzobo K. The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer. Int J Mol Sci 2017;18:E1586. [PMID: 28754000 DOI: 10.3390/ijms18071586] [Cited by in Crossref: 153] [Cited by in F6Publishing: 145] [Article Influence: 30.6] [Reference Citation Analysis]
Number Citing Articles
1 Yeldag G, Rice A, Del Río Hernández A. Chemoresistance and the Self-Maintaining Tumor Microenvironment. Cancers (Basel) 2018;10:E471. [PMID: 30487436 DOI: 10.3390/cancers10120471] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 14.5] [Reference Citation Analysis]
2 Bermúdez M, Aguilar-Medina M, Lizárraga-Verdugo E, Avendaño-Félix M, Silva-Benítez E, López-Camarillo C, Ramos-Payán R. LncRNAs as Regulators of Autophagy and Drug Resistance in Colorectal Cancer. Front Oncol 2019;9:1008. [PMID: 31632922 DOI: 10.3389/fonc.2019.01008] [Cited by in Crossref: 36] [Cited by in F6Publishing: 42] [Article Influence: 12.0] [Reference Citation Analysis]
3 Nezhadi S, Saadat E, Handali S, Dorkoosh F. Nanomedicine and chemotherapeutics drug delivery: challenges and opportunities. J Drug Target 2021;29:185-98. [PMID: 32772739 DOI: 10.1080/1061186X.2020.1808000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Dzobo K, Rowe A, Senthebane DA, AlMazyadi MAM, Patten V, Parker MI. Three-Dimensional Organoids in Cancer Research: The Search for the Holy Grail of Preclinical Cancer Modeling. OMICS 2018;22:733-48. [PMID: 30571609 DOI: 10.1089/omi.2018.0172] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
5 Świerczewska M, Sterzyńska K, Wojtowicz K, Kaźmierczak D, Iżycki D, Nowicki M, Zabel M, Januchowski R. PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations. Int J Mol Sci 2019;20:E2053. [PMID: 31027318 DOI: 10.3390/ijms20082053] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
6 Mayer P, Kraft A, Witzel HR, Marnet N, Hörner N, Roth W, Heinrich S, Hackert T, Bergmann F, Kauczor HU, Klauss M, Gaida MM. Restricted Water Diffusion in Diffusion-Weighted Magnetic Resonance Imaging in Pancreatic Cancer is Associated with Tumor Hypoxia. Cancers (Basel) 2020;13:E89. [PMID: 33396818 DOI: 10.3390/cancers13010089] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Assaraf YG, Brozovic A, Gonçalves AC, Jurkovicova D, Linē A, Machuqueiro M, Saponara S, Sarmento-ribeiro AB, Xavier CP, Vasconcelos MH. The multi-factorial nature of clinical multidrug resistance in cancer. Drug Resistance Updates 2019;46:100645. [DOI: 10.1016/j.drup.2019.100645] [Cited by in Crossref: 81] [Cited by in F6Publishing: 80] [Article Influence: 27.0] [Reference Citation Analysis]
8 Gadde M, Phillips C, Ghousifam N, Sorace AG, Wong E, Krishnamurthy S, Syed A, Rahal O, Yankeelov TE, Woodward WA, Rylander MN. In vitro vascularized tumor platform for modeling tumor-vasculature interactions of inflammatory breast cancer. Biotechnol Bioeng 2020;117:3572-90. [PMID: 32648934 DOI: 10.1002/bit.27487] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ham IH, Lee D, Hur H. Cancer-Associated Fibroblast-Induced Resistance to Chemotherapy and Radiotherapy in Gastrointestinal Cancers. Cancers (Basel) 2021;13:1172. [PMID: 33803229 DOI: 10.3390/cancers13051172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Paneerselvam C, Ganapasam S. β-Escin alleviates cobalt chloride-induced hypoxia-mediated apoptotic resistance and invasion via ROS-dependent HIF-1α/TGF-β/MMPs in A549 cells. Toxicol Res (Camb) 2020;9:191-201. [PMID: 32670550 DOI: 10.1093/toxres/tfaa019] [Reference Citation Analysis]
11 Semba T, Sammons R, Wang X, Xie X, Dalby KN, Ueno NT. JNK Signaling in Stem Cell Self-Renewal and Differentiation. Int J Mol Sci 2020;21:E2613. [PMID: 32283767 DOI: 10.3390/ijms21072613] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
12 Martinez-Gutierrez AD, Catalan OM, Vázquez-Romo R, Porras Reyes FI, Alvarado-Miranda A, Lara Medina F, Bargallo-Rocha JE, Orozco Moreno LT, Cantú De León D, Herrera LA, López-Camarillo C, Pérez-Plasencia C, Campos-Parra AD. miRNA profile obtained by next‑generation sequencing in metastatic breast cancer patients is able to predict the response to systemic treatments. Int J Mol Med 2019;44:1267-80. [PMID: 31364724 DOI: 10.3892/ijmm.2019.4292] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
13 Yang F, Tang J, Zhao Z, Zhao C, Xiang Y. Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer. Reprod Biol Endocrinol 2021;19:178. [PMID: 34861867 DOI: 10.1186/s12958-021-00860-8] [Reference Citation Analysis]
14 Fernando K, Kwang LG, Lim JTC, Fong ELS. Hydrogels to engineer tumor microenvironments in vitro. Biomater Sci 2021;9:2362-83. [DOI: 10.1039/d0bm01943g] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
15 Mahadevan S, Cornwell JA, Chami B, Kelly E, Zoellner H. Cell-Projection Pumping of Fibroblast Contents into Osteosarcoma SAOS-2 Cells Correlates with Increased SAOS-2 Proliferation and Migration, as well as Altered Morphology. Biomolecules 2021;11:1875. [DOI: 10.3390/biom11121875] [Reference Citation Analysis]
16 Dzobo K, Ganz C, Thomford NE, Senthebane DA. Cancer Stem Cell Markers in Relation to Patient Survival Outcomes: Lessons for Integrative Diagnostics and Next-Generation Anticancer Drug Development. OMICS 2021;25:81-92. [PMID: 33170084 DOI: 10.1089/omi.2020.0185] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
17 Park JY, Park SH, Kim MG, Park SH, Yoo TH, Kim MS. Biomimetic Scaffolds for Bone Tissue Engineering. Adv Exp Med Biol 2018;1064:109-21. [PMID: 30471029 DOI: 10.1007/978-981-13-0445-3_7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
18 Desa DE, Bhanote M, Hill RL, Majeski JB, Buscaglia B, D'Aguiar M, Strawderman R, Hicks DG, Turner BM, Brown EB. Second-harmonic generation directionality is associated with neoadjuvant chemotherapy response in breast cancer core needle biopsies. J Biomed Opt 2019;24:1-9. [PMID: 31456385 DOI: 10.1117/1.JBO.24.8.086503] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
19 Pietilä EA, Gonzalez-Molina J, Moyano-Galceran L, Jamalzadeh S, Zhang K, Lehtinen L, Turunen SP, Martins TA, Gultekin O, Lamminen T, Kaipio K, Joneborg U, Hynninen J, Hietanen S, Grénman S, Lehtonen R, Hautaniemi S, Carpén O, Carlson JW, Lehti K. Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance. Nat Commun 2021;12:3904. [PMID: 34162871 DOI: 10.1038/s41467-021-24009-8] [Reference Citation Analysis]
20 Zakaria MA, Rajab NF, Chua EW, Selvarajah GT, Masre SF. The Roles of Tissue Rigidity and Its Underlying Mechanisms in Promoting Tumor Growth. Cancer Invest 2020;38:445-62. [PMID: 32713210 DOI: 10.1080/07357907.2020.1802474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Fedorchuk O, Susak Y, Rudyk M, Senchylo N, Khranovska N, Skachkova O, Skivka L. Immunological hallmarks of cis-DDP-resistant Lewis lung carcinoma cells. Cancer Chemother Pharmacol 2018;81:373-85. [PMID: 29290023 DOI: 10.1007/s00280-017-3503-6] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
22 Schoonjans CA, Gallez B. Metabolic Plasticity of Tumor Cells: How They Do Adapt to Food Deprivation. Adv Exp Med Biol 2020;1219:109-23. [PMID: 32130696 DOI: 10.1007/978-3-030-34025-4_6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Phi LTH, Sari IN, Yang YG, Lee SH, Jun N, Kim KS, Lee YK, Kwon HY. Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment. Stem Cells Int. 2018;2018:5416923. [PMID: 29681949 DOI: 10.1155/2018/5416923] [Cited by in Crossref: 193] [Cited by in F6Publishing: 208] [Article Influence: 48.3] [Reference Citation Analysis]
24 Manna D, Sarkar D. Multifunctional Role of Astrocyte Elevated Gene-1 (AEG-1) in Cancer: Focus on Drug Resistance. Cancers (Basel) 2021;13:1792. [PMID: 33918653 DOI: 10.3390/cancers13081792] [Reference Citation Analysis]
25 Dzobo K. Epigenomics-Guided Drug Development: Recent Advances in Solving the Cancer Treatment "jigsaw puzzle". OMICS 2019;23:70-85. [PMID: 30767728 DOI: 10.1089/omi.2018.0206] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
26 Dzobo K. What to Do for Increasing Cancer Burden on the African Continent? Accelerating Public Health Diagnostics Innovation for Prevention and Early Intervention on Cancers. OMICS 2021. [PMID: 34399067 DOI: 10.1089/omi.2021.0098] [Reference Citation Analysis]
27 Madamsetty VS, Pal K, Dutta SK, Wang E, Mukhopadhyay D. Targeted Dual Intervention-Oriented Drug-Encapsulated (DIODE) Nanoformulations for Improved Treatment of Pancreatic Cancer. Cancers (Basel) 2020;12:E1189. [PMID: 32397114 DOI: 10.3390/cancers12051189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Cortini M, Baldini N, Avnet S. New Advances in the Study of Bone Tumors: A Lesson From the 3D Environment. Front Physiol 2019;10:814. [PMID: 31316395 DOI: 10.3389/fphys.2019.00814] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
29 Ni Y, Zhou X, Yang J, Shi H, Li H, Zhao X, Ma X. The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment. Front Cell Dev Biol 2021;9:637675. [PMID: 34095111 DOI: 10.3389/fcell.2021.637675] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Dzobo K, Senthebane DA, Ganz C, Thomford NE, Wonkam A, Dandara C. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review. Cells 2020;9:E1896. [PMID: 32823711 DOI: 10.3390/cells9081896] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
31 Pasello M, Giudice AM, Scotlandi K. The ABC subfamily A transporters: Multifaceted players with incipient potentialities in cancer. Semin Cancer Biol 2020;60:57-71. [PMID: 31605751 DOI: 10.1016/j.semcancer.2019.10.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 11.0] [Reference Citation Analysis]
32 Yang Y, Liu S, Chen C, Huang H, Tao L, Qian Z, Li W. Microfluidic-enabled self-organized tumor model for in vitro cytotoxicity assessment of doxorubicin. Biomed Microdevices 2020;22:70. [PMID: 32960346 DOI: 10.1007/s10544-020-00523-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Guerriero C, Matera C, Del Bufalo D, De Amici M, Conti L, Dallanoce C, Tata AM. The Combined Treatment with Chemotherapeutic Agents and the Dualsteric Muscarinic Agonist Iper-8-Naphthalimide Affects Drug Resistance in Glioblastoma Stem Cells. Cells 2021;10:1877. [PMID: 34440646 DOI: 10.3390/cells10081877] [Reference Citation Analysis]
34 Yang J, Gong Y, Sontag DP, Corbin I, Minuk GY. Effects of low-density lipoprotein docosahexaenoic acid nanoparticles on cancer stem cells isolated from human hepatoma cell lines. Mol Biol Rep 2018;45:1023-36. [DOI: 10.1007/s11033-018-4252-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
35 Miller AK, Brown JS, Basanta D, Huntly N. What Is the Storage Effect, Why Should It Occur in Cancers, and How Can It Inform Cancer Therapy? Cancer Control 2020;27:1073274820941968. [PMID: 32723185 DOI: 10.1177/1073274820941968] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
36 Takahashi Y, Gleber-Netto FO, Bell D, Roberts D, Xie TX, Abdelmeguid AS, Pickering C, Myers JN, Hanna EY. Identification of markers predictive for response to induction chemotherapy in patients with sinonasal undifferentiated carcinoma. Oral Oncol 2019;97:56-61. [PMID: 31421472 DOI: 10.1016/j.oraloncology.2019.07.028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
37 Garvey CM, Lau R, Sanchez A, Sun RX, Fong EJ, Doche ME, Chen O, Jusuf A, Lenz HJ, Larson B, Mumenthaler SM. Anti-EGFR Therapy Induces EGF Secretion by Cancer-Associated Fibroblasts to Confer Colorectal Cancer Chemoresistance. Cancers (Basel) 2020;12:E1393. [PMID: 32481658 DOI: 10.3390/cancers12061393] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
38 Dzobo K, Senthebane DA, Thomford NE, Rowe A, Dandara C, Parker MI. Not Everyone Fits the Mold: Intratumor and Intertumor Heterogeneity and Innovative Cancer Drug Design and Development. OMICS 2018;22:17-34. [PMID: 29356626 DOI: 10.1089/omi.2017.0174] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
39 Jokela TA, LaBarge MA. Integration of mechanical and ECM microenvironment signals in the determination of cancer stem cell states. Curr Stem Cell Rep 2021;7:39-47. [PMID: 33777660 DOI: 10.1007/s40778-020-00182-2] [Reference Citation Analysis]
40 Tomita R, Sasabe E, Tomomura A, Yamamoto T. Macrophage‑derived exosomes attenuate the susceptibility of oral squamous cell carcinoma cells to chemotherapeutic drugs through the AKT/GSK‑3β pathway. Oncol Rep 2020;44:1905-16. [PMID: 32901850 DOI: 10.3892/or.2020.7748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Bae JA, Bae WK, Kim SJ, Ko YS, Kim KY, Park SY, Yu YH, Kim EA, Chung IJ, Kim H, Ha HH, Kim KK. A new KSRP-binding compound suppresses distant metastasis of colorectal cancer by targeting the oncogenic KITENIN complex. Mol Cancer 2021;20:78. [PMID: 34039363 DOI: 10.1186/s12943-021-01368-w] [Reference Citation Analysis]
42 Hoarau-Véchot J, Rafii A, Touboul C, Pasquier J. Halfway between 2D and Animal Models: Are 3D Cultures the Ideal Tool to Study Cancer-Microenvironment Interactions? Int J Mol Sci 2018;19:E181. [PMID: 29346265 DOI: 10.3390/ijms19010181] [Cited by in Crossref: 148] [Cited by in F6Publishing: 129] [Article Influence: 37.0] [Reference Citation Analysis]
43 Zhang Z, Li Z, Liu Z, Zhang X, Yu N, Xu Z. Identification of microenvironment-related genes with prognostic value in clear cell renal cell carcinoma. J Cell Biochem 2020;121:3606-15. [PMID: 31961022 DOI: 10.1002/jcb.29654] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Rossi SM, Murray TE, Cassidy J, Lee MJ, Kelly HM. A Custom Radiopaque Thermoresponsive Chemotherapy-Loaded Hydrogel for Intratumoural Injection: An In Vitro and Ex Vivo Assessment of Imaging Characteristics and Material Properties. Cardiovasc Intervent Radiol 2019;42:289-97. [PMID: 30390105 DOI: 10.1007/s00270-018-2103-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
45 Zhang Y, Lin C, Wang X, Ji T. Calcitonin gene-related peptide: A promising bridge between cancer development and cancer-associated pain in oral squamous cell carcinoma. Oncol Lett 2020;20:253. [PMID: 32994816 DOI: 10.3892/ol.2020.12116] [Reference Citation Analysis]
46 Alkasalias T, Moyano-Galceran L, Arsenian-Henriksson M, Lehti K. Fibroblasts in the Tumor Microenvironment: Shield or Spear? Int J Mol Sci 2018;19:E1532. [PMID: 29883428 DOI: 10.3390/ijms19051532] [Cited by in Crossref: 88] [Cited by in F6Publishing: 81] [Article Influence: 22.0] [Reference Citation Analysis]
47 Kim HY, Jo M, La JA, Choi Y, Cho EC, Kim SH, Jung Y, Kim K, Ryu JH. Detection of Lysyl Oxidase Activity in Tumor Extracellular Matrix Using Peptide-Functionalized Gold Nanoprobes. Cancers (Basel) 2021;13:4523. [PMID: 34572752 DOI: 10.3390/cancers13184523] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Arolt C, Meyer M, Hoffmann F, Wagener-Ryczek S, Schwarz D, Nachtsheim L, Beutner D, Odenthal M, Guntinas-Lichius O, Buettner R, von Eggeling F, Klußmann JP, Quaas A. Expression Profiling of Extracellular Matrix Genes Reveals Global and Entity-Specific Characteristics in Adenoid Cystic, Mucoepidermoid and Salivary Duct Carcinomas. Cancers (Basel) 2020;12:E2466. [PMID: 32878206 DOI: 10.3390/cancers12092466] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
49 Rafaeva M, Erler JT. Framing cancer progression: influence of the organ- and tumour-specific matrisome. FEBS J 2020;287:1454-77. [PMID: 31972068 DOI: 10.1111/febs.15223] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
50 Zheng Y, Ye J, Li Z, Chen H, Gao Y. Recent progress in sono-photodynamic cancer therapy: From developed new sensitizers to nanotechnology-based efficacy-enhancing strategies. Acta Pharm Sin B 2021;11:2197-219. [PMID: 34522584 DOI: 10.1016/j.apsb.2020.12.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
51 Maruhashi R, Eguchi H, Akizuki R, Hamada S, Furuta T, Matsunaga T, Endo S, Ichihara K, Ikari A. Chrysin enhances anticancer drug-induced toxicity mediated by the reduction of claudin-1 and 11 expression in a spheroid culture model of lung squamous cell carcinoma cells. Sci Rep 2019;9:13753. [PMID: 31551535 DOI: 10.1038/s41598-019-50276-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
52 Sterzyńska K, Kaźmierczak D, Klejewski A, Świerczewska M, Wojtowicz K, Nowacka M, Brązert J, Nowicki M, Januchowski R. Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated with Drug Resistance in Ovarian Cancer Cell Lines. Int J Mol Sci 2019;20:E3927. [PMID: 31412536 DOI: 10.3390/ijms20163927] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
53 Papazoglou ED, Jagirdar RM, Kouliou OA, Pitaraki E, Hatzoglou C, Gourgoulianis KI, Zarogiannis SG. In Vitro Characterization of Cisplatin and Pemetrexed Effects in Malignant Pleural Mesothelioma 3D Culture Phenotypes. Cancers (Basel) 2019;11:E1446. [PMID: 31569615 DOI: 10.3390/cancers11101446] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
54 Andreucci E, Ruzzolini J, Peppicelli S, Bianchini F, Laurenzana A, Carta F, Supuran CT, Calorini L. The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy. J Enzyme Inhib Med Chem 2019;34:117-23. [PMID: 30362384 DOI: 10.1080/14756366.2018.1532419] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 9.5] [Reference Citation Analysis]
55 Senthebane DA, Jonker T, Rowe A, Thomford NE, Munro D, Dandara C, Wonkam A, Govender D, Calder B, Soares NC, Blackburn JM, Parker MI, Dzobo K. The Role of Tumor Microenvironment in Chemoresistance: 3D Extracellular Matrices as Accomplices. Int J Mol Sci 2018;19:E2861. [PMID: 30241395 DOI: 10.3390/ijms19102861] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 12.8] [Reference Citation Analysis]
56 Peixoto A, Relvas-Santos M, Azevedo R, Santos LL, Ferreira JA. Protein Glycosylation and Tumor Microenvironment Alterations Driving Cancer Hallmarks. Front Oncol 2019;9:380. [PMID: 31157165 DOI: 10.3389/fonc.2019.00380] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 23.7] [Reference Citation Analysis]
57 Chu HY, Chen YJ, Hsu CJ, Liu YW, Chiou JF, Lu LS, Tseng FG. Physical Cues in the Microenvironment Regulate Stemness-Dependent Homing of Breast Cancer Cells. Cancers (Basel) 2020;12:E2176. [PMID: 32764400 DOI: 10.3390/cancers12082176] [Reference Citation Analysis]
58 Kumari S, Advani D, Sharma S, Ambasta RK, Kumar P. Combinatorial therapy in tumor microenvironment: Where do we stand? Biochim Biophys Acta Rev Cancer 2021;1876:188585. [PMID: 34224836 DOI: 10.1016/j.bbcan.2021.188585] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
59 Jing Y, Liang W, Liu J, Zhang L, Wei J, Yang J, Zhang Y, Huang Z. Autophagy-mediating microRNAs in cancer chemoresistance. Cell Biol Toxicol 2020;36:517-36. [PMID: 32875398 DOI: 10.1007/s10565-020-09553-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
60 Maurya SK, Shadab G, Siddique HR. Chemosensitization of Therapy Resistant Tumors: Targeting Multiple Cell Signaling Pathways by Lupeol, A Pentacyclic Triterpene. CPD 2020;26:455-65. [DOI: 10.2174/1381612826666200122122804] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
61 Alhawarat FM, Hammad HM, Hijjawi MS, Sharab AS, Abuarqoub DA, Al Shhab MA, Zihlif MA. The effect of cycling hypoxia on MCF-7 cancer stem cells and the impact of their microenvironment on angiogenesis using human umbilical vein endothelial cells (HUVECs) as a model. PeerJ 2019;7:e5990. [PMID: 30729067 DOI: 10.7717/peerj.5990] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
62 Moyano-Galceran L, Pietilä EA, Turunen SP, Corvigno S, Hjerpe E, Bulanova D, Joneborg U, Alkasalias T, Miki Y, Yashiro M, Chernenko A, Jukonen J, Singh M, Dahlstrand H, Carlson JW, Lehti K. Adaptive RSK-EphA2-GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer. EMBO Mol Med 2020;12:e11177. [PMID: 32115889 DOI: 10.15252/emmm.201911177] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
63 Russi S, Verma HK, Laurino S, Mazzone P, Storto G, Nardelli A, Zoppoli P, Calice G, La Rocca F, Sgambato A, Lucci V, Falco G, Ruggieri V. Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells. Int J Mol Sci 2019;20:E3736. [PMID: 31370155 DOI: 10.3390/ijms20153736] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
64 Wei Z, Yin X, Cai Y, Xu W, Song C, Wang Y, Zhang J, Kang A, Wang Z, Han W. Antitumor effect of a Pt-loaded nanocomposite based on graphene quantum dots combats hypoxia-induced chemoresistance of oral squamous cell carcinoma. Int J Nanomedicine 2018;13:1505-24. [PMID: 29559779 DOI: 10.2147/IJN.S156984] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
65 Wang Z, Deng Z, Zhu G. Emerging platinum(iv) prodrugs to combat cisplatin resistance: from isolated cancer cells to tumor microenvironment. Dalton Trans 2019;48:2536-44. [PMID: 30633263 DOI: 10.1039/c8dt03923b] [Cited by in Crossref: 47] [Cited by in F6Publishing: 10] [Article Influence: 15.7] [Reference Citation Analysis]
66 Zhu Y, Ferri-Borgogno S, Sheng J, Yeung TL, Burks JK, Cappello P, Jazaeri AA, Kim JH, Han GH, Birrer MJ, Mok SC, Wong STC. SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor Microenvironment. Cancers (Basel) 2021;13:1777. [PMID: 33917869 DOI: 10.3390/cancers13081777] [Reference Citation Analysis]
67 Abreu S, Silva F, Mendes R, Mendes TF, Teixeira M, Santo VE, Boghaert ER, Félix A, Brito C. Patient-derived ovarian cancer explants: preserved viability and histopathological features in long-term agitation-based cultures. Sci Rep 2020;10:19462. [PMID: 33173111 DOI: 10.1038/s41598-020-76291-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
68 Dzobo K, Sinkala M. Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression/Evasion, Drug Resistance, Epithelial-Mesenchymal Transition, and Metastasis. OMICS 2021;25:313-32. [PMID: 33961518 DOI: 10.1089/omi.2021.0025] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
69 Soman SS, Vijayavenkataraman S. Applications of 3D Bioprinted-Induced Pluripotent Stem Cells in Healthcare. Int J Bioprint 2020;6:280. [PMID: 33088994 DOI: 10.18063/ijb.v6i4.280] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
70 Eguchi H, Akizuki R, Maruhashi R, Tsukimoto M, Furuta T, Matsunaga T, Endo S, Ikari A. Increase in resistance to anticancer drugs involves occludin in spheroid culture model of lung adenocarcinoma A549 cells. Sci Rep 2018;8:15157. [PMID: 30310131 DOI: 10.1038/s41598-018-33566-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
71 Eguchi H, Matsunaga T, Endo S, Ichihara K, Ikari A. Kaempferide Enhances Chemosensitivity of Human Lung Adenocarcinoma A549 Cells Mediated by the Decrease in Phosphorylation of Akt and Claudin-2 Expression. Nutrients 2020;12:E1190. [PMID: 32340376 DOI: 10.3390/nu12041190] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
72 Mierke CT. The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells. Rep Prog Phys 2019;82:064602. [PMID: 30947151 DOI: 10.1088/1361-6633/ab1628] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 15.0] [Reference Citation Analysis]
73 Saini H, Rahmani Eliato K, Silva C, Allam M, Mouneimne G, Ros R, Nikkhah M. The Role of Desmoplasia and Stromal Fibroblasts on Anti-cancer Drug Resistance in a Microengineered Tumor Model. Cell Mol Bioeng 2018;11:419-33. [PMID: 31719892 DOI: 10.1007/s12195-018-0544-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
74 Leiva MC, Garre E, Gustafsson A, Svanström A, Bogestål Y, Håkansson J, Ståhlberg A, Landberg G. Breast cancer patient-derived scaffolds as a tool to monitor chemotherapy responses in human tumor microenvironments. J Cell Physiol 2021;236:4709-24. [PMID: 33368325 DOI: 10.1002/jcp.30191] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
75 Kong W, Ling X, Chen Y, Wu X, Zhao Z, Wang W, Wang S, Lai G, Yu Z. Hesperetin reverses P‑glycoprotein‑mediated cisplatin resistance in DDP‑resistant human lung cancer cells via modulation of the nuclear factor‑κB signaling pathway. Int J Mol Med 2020;45:1213-24. [PMID: 32124932 DOI: 10.3892/ijmm.2020.4485] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
76 Bhattacharya S, Calar K, de la Puente P. Mimicking tumor hypoxia and tumor-immune interactions employing three-dimensional in vitro models. J Exp Clin Cancer Res 2020;39:75. [PMID: 32357910 DOI: 10.1186/s13046-020-01583-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
77 Dzobo K. Recent Trends in Multipotent Human Mesenchymal Stem/Stromal Cells: Learning from History and Advancing Clinical Applications. OMICS 2021;25:342-57. [PMID: 34115524 DOI: 10.1089/omi.2021.0049] [Reference Citation Analysis]
78 Hassan S, Peluso J, Chalhoub S, Idoux Gillet Y, Benkirane-Jessel N, Rochel N, Fuhrmann G, Ubeaud-Sequier G. Quercetin potentializes the respective cytotoxic activity of gemcitabine or doxorubicin on 3D culture of AsPC-1 or HepG2 cells, through the inhibition of HIF-1α and MDR1. PLoS One 2020;15:e0240676. [PMID: 33052979 DOI: 10.1371/journal.pone.0240676] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
79 Freeman FE, Burdis R, Mahon OR, Kelly DJ, Artzi N. A Spheroid Model of Early and Late-Stage Osteosarcoma Mimicking the Divergent Relationship between Tumor Elimination and Bone Regeneration. Adv Healthc Mater 2021;:e2101296. [PMID: 34636176 DOI: 10.1002/adhm.202101296] [Reference Citation Analysis]
80 Boedtkjer E. Na+,HCO3− cotransporter NBCn1 accelerates breast carcinogenesis. Cancer Metastasis Rev 2019;38:165-78. [DOI: 10.1007/s10555-019-09784-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
81 Lee-Thedieck C, Schertl P, Klein G. The extracellular matrix of hematopoietic stem cell niches. Adv Drug Deliv Rev 2021;:114069. [PMID: 34838648 DOI: 10.1016/j.addr.2021.114069] [Reference Citation Analysis]
82 Jin KT, Lu ZB, Lv JQ, Zhang JG. The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer. RNA Biol 2020;17:1727-40. [PMID: 32129701 DOI: 10.1080/15476286.2020.1737787] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
83 Guo J, Zhang Z, Ding K. A patent review of discoidin domain receptor 1 (DDR1) modulators (2014-present). Expert Opin Ther Pat 2020;30:341-50. [PMID: 32077340 DOI: 10.1080/13543776.2020.1732925] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
84 Zhang WJ, Hu CG, Zhu ZM, Luo HL. Effect of P2X7 receptor on tumorigenesis and its pharmacological properties. Biomed Pharmacother 2020;125:109844. [PMID: 32004973 DOI: 10.1016/j.biopha.2020.109844] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
85 Dianat-moghadam H, Heidarifard M, Jahanban-esfahlan R, Panahi Y, Hamishehkar H, Pouremamali F, Rahbarghazi R, Nouri M. Cancer stem cells-emanated therapy resistance: Implications for liposomal drug delivery systems. Journal of Controlled Release 2018;288:62-83. [DOI: 10.1016/j.jconrel.2018.08.043] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 11.3] [Reference Citation Analysis]
86 Chen WC, Hu G, Hazlehurst LA. Contribution of the bone marrow stromal cells in mediating drug resistance in hematopoietic tumors. Curr Opin Pharmacol 2020;54:36-43. [PMID: 32898723 DOI: 10.1016/j.coph.2020.08.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
87 Choodetwattana P, Proungvitaya S, Jearanaikoon P, Limpaiboon T. The Upregulation of OCT4 in Acidic Extracellular pH is Associated with Gemcitabine Resistance in Cholangiocarcinoma Cell Lines. Asian Pac J Cancer Prev 2019;20:2745-8. [PMID: 31554372 DOI: 10.31557/APJCP.2019.20.9.2745] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
88 Fontana F, Carollo E, Melling GE, Carter DRF. Extracellular Vesicles: Emerging Modulators of Cancer Drug Resistance. Cancers (Basel) 2021;13:749. [PMID: 33670185 DOI: 10.3390/cancers13040749] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
89 Azadi S, Aboulkheyr Es H, Razavi Bazaz S, Thiery JP, Asadnia M, Ebrahimi Warkiani M. Upregulation of PD-L1 expression in breast cancer cells through the formation of 3D multicellular cancer aggregates under different chemical and mechanical conditions. Biochim Biophys Acta Mol Cell Res 2019;1866:118526. [PMID: 31398408 DOI: 10.1016/j.bbamcr.2019.118526] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
90 Peng JH, Tai Y, Zhao YX, Luo BJ, Ou QJ, Pan ZZ, Zhang L, Lu ZH. Programmed death-ligand 1 expression in the tumour stroma of colorectal liver oligometastases and its association with prognosis after liver resection. Gastroenterol Rep (Oxf) 2021;9:443-50. [PMID: 34733530 DOI: 10.1093/gastro/goaa077] [Reference Citation Analysis]
91 Dzobo K, Dandara C. Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes. OMICS 2020;24:340-51. [PMID: 32496971 DOI: 10.1089/omi.2020.0042] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
92 Vera N, Acuña-Gallardo S, Grünenwald F, Caceres-Verschae A, Realini O, Acuña R, Lladser A, Illanes SE, Varas-Godoy M. Small Extracellular Vesicles Released from Ovarian Cancer Spheroids in Response to Cisplatin Promote the Pro-Tumorigenic Activity of Mesenchymal Stem Cells. Int J Mol Sci 2019;20:E4972. [PMID: 31600881 DOI: 10.3390/ijms20204972] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
93 da Cunha BR, Domingos C, Stefanini ACB, Henrique T, Polachini GM, Castelo-Branco P, Tajara EH. Cellular Interactions in the Tumor Microenvironment: The Role of Secretome. J Cancer 2019;10:4574-87. [PMID: 31528221 DOI: 10.7150/jca.21780] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]
94 Raguraman R, Parameswaran S, Kanwar JR, Khetan V, Rishi P, Kanwar RK, Krishnakumar S. Evidence of Tumour Microenvironment and Stromal Cellular Components in Retinoblastoma. Ocul Oncol Pathol 2019;5:85-93. [PMID: 30976585 DOI: 10.1159/000488709] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
95 Ting CY, Liew SM, Price A, Gan GG, Bee-Lan Ong D, Tan SY, Bee PC. Clinical significance of aberrant microRNAs expression in predicting disease relapse/refractoriness to treatment in diffuse large B-cell lymphoma: A meta-analysis. Crit Rev Oncol Hematol 2019;144:102818. [PMID: 31733445 DOI: 10.1016/j.critrevonc.2019.102818] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
96 Wei Q, Xu Q, Yuan X, Li JJ, Chen L, Luo C, Zhu X, Ying JE. Immunological impact of chemotherapy on the tumor microenvironment in gastric cancer. J Surg Oncol 2021;123:1708-15. [PMID: 33684248 DOI: 10.1002/jso.26449] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Fourniols T, Maggio V, Rafael D, Colaco A, García Vidal E, Lopes A, Schwartz S, Martínez-Barriocanal Á, Preat V, Arango D. Colorectal cancer inhibition by BET inhibitor JQ1 is MYC-independent and not improved by nanoencapsulation. Eur J Pharm Biopharm 2022:S0939-6411(21)00272-1. [PMID: 34998911 DOI: 10.1016/j.ejpb.2021.10.017] [Reference Citation Analysis]
98 Marchandet L, Lallier M, Charrier C, Baud'huin M, Ory B, Lamoureux F. Mechanisms of Resistance to Conventional Therapies for Osteosarcoma. Cancers (Basel) 2021;13:683. [PMID: 33567616 DOI: 10.3390/cancers13040683] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
99 d’Esposito A, Sweeney PW, Ali M, Saleh M, Ramasawmy R, Roberts TA, Agliardi G, Desjardins A, Lythgoe MF, Pedley RB, Shipley R, Walker-samuel S. Computational fluid dynamics with imaging of cleared tissue and of in vivo perfusion predicts drug uptake and treatment responses in tumours. Nat Biomed Eng 2018;2:773-87. [DOI: 10.1038/s41551-018-0306-y] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 12.3] [Reference Citation Analysis]
100 Wu Q, Wang L, Wei H, Li B, Yang J, Wang Z, Xu J, Zhou YL, Zhang B. Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures. Int Immunopharmacol 2020;83:106477. [PMID: 32278127 DOI: 10.1016/j.intimp.2020.106477] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
101 Dzobo K, Hassen N, Senthebane DA, Thomford NE, Rowe A, Shipanga H, Wonkam A, Parker MI, Mowla S, Dandara C. Chemoresistance to Cancer Treatment: Benzo-α-Pyrene as Friend or Foe? Molecules 2018;23:E930. [PMID: 29673198 DOI: 10.3390/molecules23040930] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
102 Ye Y, Zhang R, Feng H. Fibronectin promotes tumor cells growth and drugs resistance through a CDC42-YAP-dependent signaling pathway in colorectal cancer. Cell Biol Int 2020;44:1840-9. [PMID: 32437085 DOI: 10.1002/cbin.11390] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
103 Barcus CE, Hwang PY, Morikis V, Brenot A, Pence P, Clarke M, Longmore GD. Tyrosine kinase-independent actions of DDR2 in tumor cells and cancer-associated fibroblasts influence tumor invasion, migration and metastasis. J Cell Sci 2021;134:jcs258431. [PMID: 34477203 DOI: 10.1242/jcs.258431] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Nunes SC. Tumor Microenvironment - Selective Pressures Boosting Cancer Progression. Adv Exp Med Biol 2020;1219:35-49. [PMID: 32130692 DOI: 10.1007/978-3-030-34025-4_2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
105 Xin X, Yang H, Zhang F, Yang S. 3D cell coculture tumor model: A promising approach for future cancer drug discovery. Process Biochemistry 2019;78:148-60. [DOI: 10.1016/j.procbio.2018.12.028] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 6.3] [Reference Citation Analysis]
106 Dzobo K. Integrins Within the Tumor Microenvironment: Biological Functions, Importance for Molecular Targeting, and Cancer Therapeutics Innovation. OMICS 2021;25:417-30. [PMID: 34191612 DOI: 10.1089/omi.2021.0069] [Reference Citation Analysis]
107 Mansur AA, Brown MT, Billington RA. The cytotoxic activity of extracts of the brown alga Cystoseira tamariscifolia (Hudson) Papenfuss, against cancer cell lines changes seasonally. J Appl Phycol 2020;32:2419-29. [DOI: 10.1007/s10811-019-02016-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
108 Kesharwani SS, Kaur S, Tummala H, Sangamwar AT. Overcoming multiple drug resistance in cancer using polymeric micelles. Expert Opinion on Drug Delivery 2018;15:1127-42. [DOI: 10.1080/17425247.2018.1537261] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
109 Sun R, Ying Y, Tang Z, Liu T, Shi F, Li H, Guo T, Huang S, Lai R. The Emerging Role of the SLCO1B3 Protein in Cancer Resistance. Protein Pept Lett 2020;27:17-29. [PMID: 31556849 DOI: 10.2174/0929866526666190926154248] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
110 Koual M, Tomkiewicz C, Cano-Sancho G, Antignac JP, Bats AS, Coumoul X. Environmental chemicals, breast cancer progression and drug resistance. Environ Health 2020;19:117. [PMID: 33203443 DOI: 10.1186/s12940-020-00670-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
111 Reyes ME, de La Fuente M, Hermoso M, Ili CG, Brebi P. Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer. Front Immunol 2020;11:901. [PMID: 32499779 DOI: 10.3389/fimmu.2020.00901] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
112 Halcrow PW, Geiger JD, Chen X. Overcoming Chemoresistance: Altering pH of Cellular Compartments by Chloroquine and Hydroxychloroquine. Front Cell Dev Biol 2021;9:627639. [PMID: 33634129 DOI: 10.3389/fcell.2021.627639] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
113 Dzobo K, Dandara C. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance. OMICS 2020;24:314-39. [PMID: 32496970 DOI: 10.1089/omi.2020.0023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
114 Hong S, Song JM. 3D bioprinted drug-resistant breast cancer spheroids for quantitative in situ evaluation of drug resistance. Acta Biomater 2021:S1742-7061(21)00697-8. [PMID: 34718182 DOI: 10.1016/j.actbio.2021.10.031] [Reference Citation Analysis]
115 Krishnan SM, Laarif SS, Bender BC, Quartino AL, Friberg LE. Tumor growth inhibition modeling of individual lesion dynamics and interorgan variability in HER2-negative breast cancer patients treated with docetaxel. CPT Pharmacometrics Syst Pharmacol 2021;10:511-21. [PMID: 33818899 DOI: 10.1002/psp4.12629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
116 Lin Z, Fan Z, Zhang X, Wan J, Liu T. Cellular plasticity and drug resistance in sarcoma. Life Sci 2020;263:118589. [PMID: 33069737 DOI: 10.1016/j.lfs.2020.118589] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
117 Stefanski CD, Prosperi JR. Wnt-Independent and Wnt-Dependent Effects of APC Loss on the Chemotherapeutic Response. Int J Mol Sci 2020;21:E7844. [PMID: 33105836 DOI: 10.3390/ijms21217844] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
118 Qin X, Lu M, Li G, Zhou Y, Liu Z. Downregulation of tumor-derived exosomal miR-34c induces cancer-associated fibroblast activation to promote cholangiocarcinoma progress. Cancer Cell Int 2021;21:373. [PMID: 34261453 DOI: 10.1186/s12935-020-01726-6] [Reference Citation Analysis]
119 Low LE, Wu J, Lee J, Tey BT, Goh B, Gao J, Li F, Ling D. Tumor-responsive dynamic nanoassemblies for targeted imaging, therapy and microenvironment manipulation. Journal of Controlled Release 2020;324:69-103. [DOI: 10.1016/j.jconrel.2020.05.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
120 Alves C, Serrano E, Silva J, Rodrigues C, Pinteus S, Gaspar H, Botana LM, Alpoim MC, Pedrosa R. Sphaerococcus coronopifolius bromoterpenes as potential cancer stem cell-targeting agents. Biomed Pharmacother 2020;128:110275. [PMID: 32480221 DOI: 10.1016/j.biopha.2020.110275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
121 Qin X, Guo H, Wang X, Zhu X, Yan M, Wang X, Xu Q, Shi J, Lu E, Chen W, Zhang J. Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5. Genome Biol 2019;20:12. [PMID: 30642385 DOI: 10.1186/s13059-018-1604-0] [Cited by in Crossref: 121] [Cited by in F6Publishing: 125] [Article Influence: 40.3] [Reference Citation Analysis]
122 Sharbatoghli M, Vafaei S, Aboulkheyr Es H, Asadi-Lari M, Totonchi M, Madjd Z. Prediction of the treatment response in ovarian cancer: a ctDNA approach. J Ovarian Res 2020;13:124. [PMID: 33076944 DOI: 10.1186/s13048-020-00729-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
123 Aggarwal V, Miranda O, Johnston PA, Sant S. Three dimensional engineered models to study hypoxia biology in breast cancer. Cancer Lett 2020;490:124-42. [PMID: 32569616 DOI: 10.1016/j.canlet.2020.05.030] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
124 Wang M, Zhou L, Yu F, Zhang Y, Li P, Wang K. The functional roles of exosomal long non-coding RNAs in cancer. Cell Mol Life Sci 2019;76:2059-76. [PMID: 30683984 DOI: 10.1007/s00018-019-03018-3] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 15.7] [Reference Citation Analysis]
125 Guerrero PE, Duran A, Ortiz MR, Castro E, Garcia-Velasco A, Llop E, Peracaula R. Microfibril associated protein 4 (MFAP4) is a carrier of the tumor associated carbohydrate sialyl-Lewis x (sLex) in pancreatic adenocarcinoma. J Proteomics 2021;231:104004. [PMID: 33038510 DOI: 10.1016/j.jprot.2020.104004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
126 Larionova I, Cherdyntseva N, Liu T, Patysheva M, Rakina M, Kzhyshkowska J. Interaction of tumor-associated macrophages and cancer chemotherapy. Oncoimmunology 2019;8:1596004. [PMID: 31143517 DOI: 10.1080/2162402X.2019.1596004] [Cited by in Crossref: 79] [Cited by in F6Publishing: 57] [Article Influence: 26.3] [Reference Citation Analysis]
127 Li LY, Kim HJ, Park SA, Lee SH, Kim LK, Lee JY, Kim S, Kim YT, Kim SW, Nam EJ. Genetic Profiles Associated with Chemoresistance in Patient-Derived Xenograft Models of Ovarian Cancer. Cancer Res Treat 2019;51:1117-27. [PMID: 30428638 DOI: 10.4143/crt.2018.405] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
128 Wilson RB, Archid R, Reymond MA. Reprogramming of Mesothelial-Mesenchymal Transition in Chronic Peritoneal Diseases by Estrogen Receptor Modulation and TGF-β1 Inhibition. Int J Mol Sci 2020;21:E4158. [PMID: 32532126 DOI: 10.3390/ijms21114158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
129 Doctor A, Seifert V, Ullrich M, Hauser S, Pietzsch J. Three-Dimensional Cell Culture Systems in Radiopharmaceutical Cancer Research. Cancers (Basel). 2020;12. [PMID: 32993034 DOI: 10.3390/cancers12102765] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
130 Valdebenito S, Lou E, Baldoni J, Okafo G, Eugenin E. The Novel Roles of Connexin Channels and Tunneling Nanotubes in Cancer Pathogenesis. Int J Mol Sci 2018;19:E1270. [PMID: 29695070 DOI: 10.3390/ijms19051270] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
131 Houthuijzen JM, Jonkers J. Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment. Cancer Metastasis Rev 2018;37:577-97. [PMID: 30465162 DOI: 10.1007/s10555-018-9768-3] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 19.7] [Reference Citation Analysis]
132 Horst EN, Bregenzer ME, Mehta P, Snyder CS, Repetto T, Yang-Hartwich Y, Mehta G. Personalized models of heterogeneous 3D epithelial tumor microenvironments: Ovarian cancer as a model. Acta Biomater 2021:S1742-7061(21)00285-3. [PMID: 33940195 DOI: 10.1016/j.actbio.2021.04.041] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 Jena BC, Das CK, Bharadwaj D, Mandal M. Cancer associated fibroblast mediated chemoresistance: A paradigm shift in understanding the mechanism of tumor progression. Biochim Biophys Acta Rev Cancer 2020;1874:188416. [PMID: 32822826 DOI: 10.1016/j.bbcan.2020.188416] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
134 Winkler J, Abisoye-Ogunniyan A, Metcalf KJ, Werb Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis.Nat Commun. 2020;11:5120. [PMID: 33037194 DOI: 10.1038/s41467-020-18794-x] [Cited by in Crossref: 111] [Cited by in F6Publishing: 117] [Article Influence: 55.5] [Reference Citation Analysis]
135 Kanbayti IH, Rae WID, McEntee MF, Ekpo EU. Are mammographic density phenotypes associated with breast cancer treatment response and clinical outcomes? A systematic review and meta-analysis. Breast 2019;47:62-76. [PMID: 31352313 DOI: 10.1016/j.breast.2019.07.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
136 Alberti D, Michelotti A, Lanfranco A, Protti N, Altieri S, Deagostino A, Geninatti Crich S. In vitro and in vivo BNCT investigations using a carborane containing sulfonamide targeting CAIX epitopes on malignant pleural mesothelioma and breast cancer cells. Sci Rep 2020;10:19274. [PMID: 33159147 DOI: 10.1038/s41598-020-76370-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
137 Chai JY, Sugumar V, Alshanon AF, Wong WF, Fung SY, Looi CY. Defining the Role of GLI/Hedgehog Signaling in Chemoresistance: Implications in Therapeutic Approaches. Cancers (Basel) 2021;13:4746. [PMID: 34638233 DOI: 10.3390/cancers13194746] [Reference Citation Analysis]
138 Rustum YM, Chintala S, Durrani FA, Bhattacharya A. Non-Coding Micro RNAs and Hypoxia-Inducible Factors Are Selenium Targets for Development of a Mechanism-Based Combination Strategy in Clear-Cell Renal Cell Carcinoma-Bench-to-Bedside Therapy. Int J Mol Sci 2018;19:E3378. [PMID: 30380599 DOI: 10.3390/ijms19113378] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
139 Sylvestre M, Tarte K, Roulois D. Epigenetic mechanisms driving tumor supportive microenvironment differentiation and function: a role in cancer therapy? Epigenomics 2020;12:157-69. [PMID: 31849241 DOI: 10.2217/epi-2019-0165] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
140 Sun Z, Wang L, Dong L, Wang X. Emerging role of exosome signalling in maintaining cancer stem cell dynamic equilibrium. J Cell Mol Med. 2018;. [PMID: 29799161 DOI: 10.1111/jcmm.13676] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
141 Xiao W, Wang L, Howard J, Kolhe R, Rojiani AM, Rojiani MV. TIMP-1-Mediated Chemoresistance via Induction of IL-6 in NSCLC. Cancers (Basel) 2019;11:E1184. [PMID: 31443242 DOI: 10.3390/cancers11081184] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
142 Dominijanni A, Devarasetty M, Soker S. Manipulating the Tumor Microenvironment in Tumor Organoids Induces Phenotypic Changes and Chemoresistance. iScience 2020;23:101851. [PMID: 33319176 DOI: 10.1016/j.isci.2020.101851] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
143 Phi LTH, Sari IN, Wijaya YT, Kim KS, Park K, Cho AE, Kwon HY. Ginsenoside Rd Inhibits the Metastasis of Colorectal Cancer via Epidermal Growth Factor Receptor Signaling Axis. IUBMB Life 2019;71:601-10. [PMID: 30576064 DOI: 10.1002/iub.1984] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
144 Huang G, Pan ST. ROS-Mediated Therapeutic Strategy in Chemo-/Radiotherapy of Head and Neck Cancer. Oxid Med Cell Longev 2020;2020:5047987. [PMID: 32774675 DOI: 10.1155/2020/5047987] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
145 Xing X, Wang Y, Zhang X, Gao X, Li M, Wu S, Zhao Y, Chen J, Gao D, Chen R, Ren Z, Zhang K, Cui J. Matrix stiffness-mediated effects on macrophages polarization and their LOXL2 expression. FEBS J 2021;288:3465-77. [PMID: 32964626 DOI: 10.1111/febs.15566] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
146 Mondal P, Kaur B, Natesh J, Meeran SM. The emerging role of miRNA in the perturbation of tumor immune microenvironment in chemoresistance: Therapeutic implications. Semin Cell Dev Biol 2021:S1084-9521(21)00074-4. [PMID: 33865701 DOI: 10.1016/j.semcdb.2021.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
147 Dzobo K. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic. OMICS 2020;24:175-9. [PMID: 32176591 DOI: 10.1089/omi.2020.0019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
148 Snow O, Lallous N, Singh K, Lack N, Rennie P, Cherkasov A. Androgen receptor plasticity and its implications for prostate cancer therapy. Cancer Treat Rev 2019;81:101871. [PMID: 31698174 DOI: 10.1016/j.ctrv.2019.05.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
149 Jahanafrooz Z, Mosafer J, Akbari M, Hashemzaei M, Mokhtarzadeh A, Baradaran B. Colon cancer therapy by focusing on colon cancer stem cells and their tumor microenvironment. J Cell Physiol 2020;235:4153-66. [PMID: 31647128 DOI: 10.1002/jcp.29337] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
150 Wen C, Wang H, Wang H, Mo H, Zhong W, Tang J, Lu Y, Zhou W, Tan A, Liu Y, Xie W. A three-gene signature based on tumour microenvironment predicts overall survival of osteosarcoma in adolescents and young adults. Aging (Albany NY) 2020;13:619-45. [PMID: 33281116 DOI: 10.18632/aging.202170] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
151 Nowacka M, Sterzynska K, Andrzejewska M, Nowicki M, Januchowski R. Drug resistance evaluation in novel 3D in vitro model. Biomed Pharmacother 2021;138:111536. [PMID: 34311534 DOI: 10.1016/j.biopha.2021.111536] [Reference Citation Analysis]
152 Wijeratne PA, Vavourakis V. A quantitative in silico platform for simulating cytotoxic and nanoparticle drug delivery to solid tumours. Interface Focus 2019;9:20180063. [PMID: 31065337 DOI: 10.1098/rsfs.2018.0063] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
153 Harikrishnan K, Joshi O, Madangirikar S, Balasubramanian N. Cell Derived Matrix Fibulin-1 Associates With Epidermal Growth Factor Receptor to Inhibit Its Activation, Localization and Function in Lung Cancer Calu-1 Cells. Front Cell Dev Biol 2020;8:522. [PMID: 32719793 DOI: 10.3389/fcell.2020.00522] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]